Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![biospace Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::21793154.png) BioSpace [@biospace](/creator/twitter/biospace) on x 25.1K followers
Created: 2025-07-24 13:20:07 UTC

Roche obtained CT-173, a PYY mimetic, in its $XXX billion acquisition of Carmot Therapeutics in December 2023. The company reported the change in its second quarter earnings call.

#Pharma #obesity #biospace


![](https://pbs.twimg.com/card_img/1948372627300442113/a7K5M1kV?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948372624809058320/c:line.svg)

**Related Topics**
[quarterly earnings](/topic/quarterly-earnings)
[acquisition](/topic/acquisition)

[Post Link](https://x.com/biospace/status/1948372624809058320)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

biospace Avatar BioSpace @biospace on x 25.1K followers Created: 2025-07-24 13:20:07 UTC

Roche obtained CT-173, a PYY mimetic, in its $XXX billion acquisition of Carmot Therapeutics in December 2023. The company reported the change in its second quarter earnings call.

#Pharma #obesity #biospace

XXX engagements

Engagements Line Chart

Related Topics quarterly earnings acquisition

Post Link

post/tweet::1948372624809058320
/post/tweet::1948372624809058320